EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
news

Patient Centricity Becomes a Reality with SQN Health

In drug development, patient participation is crucial to the success of clinical trials. The industry recognises the demand for better in-trial patient data and impro...
Continue Reading →
news

Engineering Solution from NUST MISIS Scientists to Significantly Decrease Costs of MRI Research

Researchers from the NUST MISIS Engineering Center for Industrial Technologies have developed an innovative technology for the production of magnetic materials and pe...
Continue Reading →
news

BioProtect Launches an International Multi-Center Clinical Study Following FDA investigational Device Exemption (IDE)

FDA has granted investigational Device Exemption approval (IDE) to conduct a pivotal clinical study examining theuse of the ProSpace[TM] Balloon System to prevent r...
Continue Reading →
news

Emotional Brain’s FSIAD Products Lybrido and Lybridos show High Efficacy and Safety in Phase 2B Trials

Emotional Brain is pleased to announce the publication of positive phase 2B results in the authoritative Journal of Sexual Medicine. Lybrido and Lybridos were success...
Continue Reading →
news

Swedish innovation can relieve tinnitus for millions of people

The medical device Antinitus breaks new ground in tinnitus treatment and research. On January 8th, the results from Sensori’s clinical placebo study of the Antinitus...
Continue Reading →
news

Ethical Issues Are Important in “Standard-of-Care” Clinical Trials

A Learning healthcare system (LHS) aligns science, informatics, incentives, and culture for continuous improvement and innovation, with a delivery process that is bas...
Continue Reading →
news

INC Research/inVentiv Health Becomes Syneos HealthTM

INC Research/inVentiv Health (Nasdaq: INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of t...
Continue Reading →
news

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker...
Continue Reading →
news

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma Clover is utilising its proprietary Trimer-Tag technology platform to develop biologics targeting trimer...
Continue Reading →
news

PathoQuest and Mayo Clinic Enter into an Agreement to Conduct Study of iDTECT™ Blood in Patients with Febrile Neutropenia

PathoQuest, a life sciences leader focused on improving pathogen identification in biological samples, today announced that it will conduct research with Mayo Clinic ...
Continue Reading →
Quotient